A late-stage clinical trial assessing the safety and effectiveness of Mirum Pharmaceuticals’ brelovitug for adults with chronic hepatitis…
Articles by Steve Bryson, PhD
The first participant has been dosed in a large clinical trial testing TGM-312, a novel gene-silencing therapy designed to slow…
Children with Alagille syndrome who have lower blood levels of bile acids, the main component of the digestive fluid…
In preclinical studies, AT-587, Atea Pharmaceuticals’ lead oral candidate for treating hepatitis E, showed potent antiviral activity against…
Among children and adolescents with progressive familial intrahepatic cholestasis (PFIC), severe itch significantly affects sleep, overall perceptions of health,…
The American Liver Foundation (ALF) has brought its “Bili the Brave” children’s book to life with a new animated…
Efforts to eliminate new hepatitis C cases by 2030, a goal set by the World Health Organization (WHO), are…
Mashnet, a network of health organizations in the U.S. and Europe, formed a coalition to broaden access to noninvasive diagnostic…
An international group of patients, clinicians, and researchers has recommended a standardized set of clinical measurements to assess outcomes in…
Vitamin D was shown to ease the effects of liver inflammation and damage in primary biliary cholangitis (PBC), a…